Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liposomes: promising perspectives]

F Bricaire

    Presse Medicale (Paris, France : 1983)
    |January 8, 1999
    PubMed
    Summary
    This summary is machine-generated.

    Liposomes offer a safer way to deliver drugs like amikacin and amphotericin B, reducing toxicity. These biodegradable lipid vectors show promise for various therapeutic applications, though cost remains a barrier.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy.

    European annals of otorhinolaryngology, head and neck diseases·2020
    Same author

    Reanimation : journal de la Societe de reanimation de langue francaise·2020
    Same author

    Chronic Lyme disease: A scam that should be condemned!

    Medecine et maladies infectieuses·2019
    Same author

    Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Proceedings of the 2nd seminar on emerging infectious diseases, December 7, 2012 – Current trends and proposals.

    Revue d'epidemiologie et de sante publique·2014
    Same author

    Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.

    European journal of neurology·2013
    Same journal

    Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Ethical, legal, and regulatory challenges in AI-based healthcare tools.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Decision-making for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    See all related articles

    Area of Science:

    • Pharmaceutical Sciences
    • Biotechnology
    • Drug Delivery Systems

    Background:

    • Liposomes are biodegradable, nontoxic lipid particles used as therapeutic drug delivery vectors.
    • They target drug compounds to specific sites, minimizing systemic toxicity.
    • This technology enhances drug efficacy and patient tolerance.

    Discussion:

    • Liposomal formulations of aminoglycosides, such as amikacin, reduce oto- and hepatic toxicity, enabling higher doses and longer treatment durations.
    • Liposomal amphotericin B demonstrates improved efficacy and tolerance.
    • Encapsulation of other agents like ciprofloxacin and foscarnet is under investigation.

    Key Insights:

    • Liposomes enhance the safety profile of potent drugs like amikacin and amphotericin B.

    Related Experiment Videos

  • Therapeutic applications extend to antibiotics, antivirals, and chemotherapy agents.
  • Targeted delivery via liposomes minimizes off-target side effects.

    • Outlook:

    • Further research into liposomal drug delivery for antibiotics, antivirals (e.g., foscarnet), and cancer therapeutics (e.g., doxorubicin) is ongoing.
    • Development aims to overcome current limitations, such as the high cost of liposome production.
    • Liposomes represent a significant advancement in targeted and safer drug administration.